Global pharmaceutical major Sanofi has named N Rajaram as the country head and general manager-pharmaceutical operations in India. He would report to Shailesh Ayyangar, vice president, South Asia, Sanofi, and managing director, Sanofi India Limited.
Rajaram had moved to Sanofi early this year as COO after a three-year stint at Bharti Airtel. At the telecom firm he served as chief marketing officer for around two years; his last position was CEO – data & digital. Prior to that, he had spent over two decades with FMCG giant Unilever.
He holds a bachelor’s degree in Electrical and Electronic Engineering from BITS, Pilani and an MBA in International Business from the India Institute of Foreign Trade.
Rajaram will be responsible for driving Sanofi’s growth plans in the pharmaceutical and consumer healthcare segments. Commenting on his new role, Rajaram said, “This is a very exciting opportunity for me. The pharmaceutical industry is witnessing a rapid change in different aspects such as innovative healthcare delivery and patient care. The prospect of playing a responsible role in making a difference in the lives of people is very exciting and fulfilling.”
Sanofi is a global healthcare firm with core strength in the fields such as diabetes solutions, human vaccines and animal health.
In India, Sanofi operates through five entities − Sanofi India Limited (previously known as Aventis Pharma Limited), Sanofi-Synthelabo (India) Limited, Sanofi Pasteur India Private Limited, Shantha Biotechnics Limited and Genzyme India Private Limited.
Sanofi India saw its revenue rise 15 per cent to Rs 1,808 crore with net profit rising 50 per cent to Rs 265.7 crore for the year ended December 31, 2013.
(Edited by Joby Puthuparampil Johnson)